As of 2026-09-11, the EV/EBITDA ratio of Asensus Surgical Inc (ASXC) is -1.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ASXC's latest enterprise value is 87.93 mil USD. ASXC's TTM EBITDA according to its financial statements is -75.08 mil USD. Dividing these 2 quantities gives us the above ASXC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 16.0x | 14.4x |
| Forward P/E multiples | 18.8x - 24.2x | 21.6x |
| Fair Price | (5.15) - (4.38) | (4.92) |
| Upside | -1581.2% - -1359.7% | -1514.3% |
| Date | EV/EBITDA |